Multiple combination therapy in cancer chemotherapy in Japan.
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002738:Chloroquine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004357:Drug Synergism; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007564:Japan; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D015122:Mercaptopurine / Q000008:administration & dosage; D008937:Mitomycins / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*; D011033:Podophyllin / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D013852:Thiotepa / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage; D010837:Vitamin K 1 / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008937:Mitomycins; D003561:Cytarabine; D014750:Vincristine; D010837:Vitamin K 1; D002738:Chloroquine; D003520:Cyclophosphamide; D011033:Podophyllin; D013852:Thiotepa; D011239:Prednisolone; D015122:Mercaptopurine; D005472:Fluorouracil